Steven Howard

4.3k total citations · 1 hit paper
91 papers, 2.4k citations indexed

About

Steven Howard is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Steven Howard has authored 91 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Genetics, 33 papers in Pulmonary and Respiratory Medicine and 21 papers in Molecular Biology. Recurrent topics in Steven Howard's work include Glioma Diagnosis and Treatment (38 papers), Brain Metastases and Treatment (16 papers) and Advanced Radiotherapy Techniques (14 papers). Steven Howard is often cited by papers focused on Glioma Diagnosis and Treatment (38 papers), Brain Metastases and Treatment (16 papers) and Advanced Radiotherapy Techniques (14 papers). Steven Howard collaborates with scholars based in United States, Canada and United Kingdom. Steven Howard's co-authors include E. Abotsi, James S. Welsh, Stephen G. Withers, Jack F. Fowler, Wolfgang A. Tomé, H. Ian Robins, Shouming He, Deepika Rajesh, Thomas F. N. Haxell and Iain Coldham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Steven Howard

87 papers receiving 2.3k citations

Hit Papers

Lignocellulose biotechnology: issues of bioconversion and... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Howard United States 26 836 600 497 377 356 91 2.4k
Balamurugan Vellayappan Singapore 21 874 1.0× 738 1.2× 391 0.8× 103 0.3× 90 0.3× 93 2.8k
Macus Tien Kuo United States 34 1.9k 2.3× 320 0.5× 208 0.4× 28 0.1× 149 0.4× 55 3.8k
Gayathri R. Devi United States 37 2.2k 2.7× 323 0.5× 635 1.3× 17 0.0× 105 0.3× 96 4.3k
Tomomi Fujii Japan 30 1.2k 1.5× 543 0.9× 103 0.2× 32 0.1× 82 0.2× 182 2.7k
Hideyuki Tominaga Japan 26 1.6k 1.9× 281 0.5× 207 0.4× 9 0.0× 152 0.4× 45 3.1k
Li‐Xi Yang United States 18 1.1k 1.3× 215 0.4× 96 0.2× 37 0.1× 109 0.3× 35 1.9k
Alain Gouyette France 32 1.8k 2.1× 303 0.5× 131 0.3× 10 0.0× 161 0.5× 105 3.2k
Richard Hill United States 28 1.3k 1.6× 238 0.4× 187 0.4× 9 0.0× 52 0.1× 48 2.6k
Yong Sun China 26 912 1.1× 354 0.6× 807 1.6× 23 0.1× 40 0.1× 83 2.3k
Evgeniy Eruslanov United States 35 1.5k 1.8× 658 1.1× 521 1.0× 5 0.0× 117 0.3× 63 5.8k

Countries citing papers authored by Steven Howard

Since Specialization
Citations

This map shows the geographic impact of Steven Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Howard more than expected).

Fields of papers citing papers by Steven Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Howard. The network helps show where Steven Howard may publish in the future.

Co-authorship network of co-authors of Steven Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Howard. A scholar is included among the top collaborators of Steven Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Howard. Steven Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gould, Michael N., et al.. (2021). Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats. Scientific Reports. 11(1). 6351–6351. 12 indexed citations
2.
Rooney, Nicholas, Susan Mason, Laura McDonald, et al.. (2020). RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome. Cancer Research. 80(11). 2325–2339. 29 indexed citations
3.
Rosenberg, Stephen A., et al.. (2018). Primary intracranial leiomyosarcoma in an immunocompetent patient: Case report and review of the literature. Clinical Neurology and Neurosurgery. 165. 76–80. 9 indexed citations
4.
Howard, Steven, et al.. (2017). The evolving role for re-irradiation in the management of recurrent grade 4 glioma. Journal of Neuro-Oncology. 134(3). 523–530. 10 indexed citations
5.
Ju, Andrew, H. Ian Robins, M. Shahriar Salamat, Allison Grayev, & Steven Howard. (2016). Radiation-Induced Spinal Glioblastoma Multiforme: A Rare Complication in the Management of Head and Neck Cancer. International Journal of Otolaryngology and Head & Neck Surgery. 5(6). 233–241. 1 indexed citations
6.
Magnuson, William J., H. Ian Robins, Pranshu Mohindra, & Steven Howard. (2014). Large volume reirradiation as salvage therapy for glioblastoma after progression on bevacizumab. Journal of Neuro-Oncology. 117(1). 133–139. 31 indexed citations
7.
Krauze, Andra, Minhee Won, B. Corn, et al.. (2013). Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM). Biomarker Research. 1(1). 29–29. 5 indexed citations
8.
Deng, Xianming, A. S. Nagle, Tao Wu, et al.. (2010). Discovery of novel 1H-imidazol-2-yl-pyrimidine-4,6-diamines as potential antimalarials. Bioorganic & Medicinal Chemistry Letters. 20(14). 4027–4031. 18 indexed citations
9.
Vite, Gregory D., Iontcho R. Vlahov, Steven Howard, et al.. (2008). Synthesis and in vitro effects of BMS-753493, an epothilone-folate conjugate designed to selectively target FR expressing tumor cells. Cancer Research. 68. 4155–4155. 2 indexed citations
10.
Adkison, Jarrod B., Bruce Thomadsen, & Steven Howard. (2008). Systemic iodine 125 activity after GliaSite brachytherapy: Safety considerations. Brachytherapy. 7(1). 43–46. 7 indexed citations
11.
Tomé, Wolfgang A. & Steven Howard. (2007). On the possible increase in local tumour control probability for gliomas exhibiting low dose hyper-radiosensitivity using a pulsed schedule. British Journal of Radiology. 80(949). 32–37. 54 indexed citations
12.
Cannon, George M., Wolfgang A. Tomé, H. Ian Robins, & Steven Howard. (2007). Pulsed reduced dose-rate radiotherapy: case report. Journal of Neuro-Oncology. 83(3). 307–311. 36 indexed citations
13.
Gallagher, Neil J., John F. Lyons, Jayne Curry, et al.. (2006). Characterisation of aurora kinase inhibitors derived from fragment based lead discovery. Cancer Research. 66. 1155–1155. 2 indexed citations
14.
Fowler, Jack F., James S. Welsh, & Steven Howard. (2004). Loss of biological effect in prolonged fraction delivery. International Journal of Radiation Oncology*Biology*Physics. 59(1). 242–249. 179 indexed citations
15.
Coldham, Iain, et al.. (2003). Preparation of diamines by lithiation–substitution of imidazolidines and pyrimidines. Organic & Biomolecular Chemistry. 1(9). 1532–1544. 21 indexed citations
16.
Welsh, James S., et al.. (2003). Thymoma and Multiple Malignancies: A Case of Five Synchronous Neoplasms and Literature Review. Clinical Medicine & Research. 1(3). 227–232. 20 indexed citations
17.
Numao, Shin, Shouming He, Gry Evjen, et al.. (2000). Identification of Asp197 as the catalytic nucleophile in the family 38 α‐mannosidase from bovine kidney lysosomes. FEBS Letters. 484(3). 175–178. 26 indexed citations
18.
Hughes‐Davies, Luke, David B. Sacks, John Rescigno, Steven Howard, & Jay R. Harris. (1995). Serum cardiac troponin T levels during treatment of early-stage breast cancer.. Journal of Clinical Oncology. 13(10). 2582–2584. 37 indexed citations
19.
Albertini, Mark R., Steven Howard, Paul Fisch, et al.. (1993). Modulation of Target-Cell Culture Conditions Alters Susceptibility to Lymphocyte-Mediated Lysis. Journal of Immunotherapy. 13(4). 243–251. 1 indexed citations
20.
Albertini, Mark R., David F. Gibson, Simon P. Robinson, et al.. (1992). Influence of Estradiol and Tamoxifen on Susceptibility of Human Breast Cancer Cell Lines to Lysis by Lymphokine-Activated Killer Cells. Journal of Immunotherapy. 11(1). 30–39. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026